Yuma Therapeutics Corporation is a private biopharmaceutical company developing novel disease-modifying small molecule compounds that modulate cellular proteostasis to treat neurodegenerative proteinopathies.
Yuma Therapeutics Corporation is a private biopharmaceutical company developing novel disease-modifying small molecule compounds that modulate cellular proteostasis to treat neurodegenerative proteinopathies.